Each tablet contains Calcium Carbonate 500 mg, Calcitriol 0.25 mcg, Eicosapentaenoic Acid (EPA) 180 mg, Docosahexaenoic Acid (DHA) 120 mg, Methylcobalamin 1500 mcg, Folic Acid 400 mcg, and Boron 1.5 mg.

Ostonex D3 Tablets are a comprehensive bone health and nutritional supplement formulated with Calcium Carbonate, Calcitriol, EPA, DHA, Methylcobalamin, Folic Acid, and Boron. The formulation helps maintain healthy calcium metabolism, supports bone mineralization, promotes normal nerve function, contributes to blood cell formation, and provides nutritional support for overall bone and skeletal health.

Ostonex D3 Tablets are indicated for the management of vitamin and mineral deficiency states in adult patients.

Ostonex D3 Tablets combine essential vitamins, minerals, and omega-3 fatty acids that work together to support bone, nerve, and overall metabolic health. Calcitriol, the active form of Vitamin D, enhances intestinal calcium absorption and helps maintain normal blood calcium levels, supporting healthy bone mineralization. Calcium Carbonate provides elemental calcium required for the maintenance of strong bones and teeth. Methylcobalamin (Vitamin B12) supports the normal functioning of the brain and nervous system and plays an important role in red blood cell formation. Folic Acid (Vitamin B9) is essential for DNA synthesis, cell division, and energy metabolism through its role in normal carbohydrate utilization. Boron is an important trace mineral that supports bone metabolism and contributes to maintaining skeletal health. Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) are long-chain omega-3 fatty acids that contribute to healthy bone development and skeletal maintenance while providing nutritional support for overall cellular function. Together, these ingredients help maintain bone strength, support neuromuscular function, and correct nutritional deficiencies.

The recommended dose is one tablet once daily, or as directed by the physician.

Ostonex D3 Tablets are contraindicated in patients with known hypersensitivity to any component of the formulation, hypercalcaemia, or hypercalciuria, including conditions such as hyperparathyroidism, decalcifying tumours, plasmacytoma, or bone metastases.